Erratum: Retraction and correction: PINK1 regulates histone H3 trimethylation and gene expression by interaction with the polycomb protein EED/WAIT1 (Proceedings of the National Academy of Sciences of the United States of America (2013) 110 (14729-14734) DOI: 10.1073/pnas.1216844110);PINK1 regulates histone H3 trimethylation and gene expression by interaction with the polycomb protein EED/WAIT1

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 36, 2013, Pages 14729-14734

  Berthier, Arnaud ^a,b   Jiménez Sáinz, Judit ^b,e   Pulido, Rafael ^a,b,c,d  

^a INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^b CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^c BIOCRUCES BIZKAIA HEALTH RESEARCH INSTITUTE   (Spain)

^d BASQUE FOUNDATION FOR SCIENCE   (Spain)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cell differentiation

Indexed keywords

ASPARTIC ACID; EMBRYONIC ECTODERM DEVELOPMENT PROTEIN; HISTONE H3; LYSINE; PHOSPHOTRANSFERASE; PTEN INDUCED PUTATIVE KINASE 1; TRYPTOPHAN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; EED PROTEIN, HUMAN; HISTONE; POLYCOMB REPRESSIVE COMPLEX 2; PROTEIN BINDING; PROTEIN KINASE; PTEN-INDUCED PUTATIVE KINASE; RETINOIC ACID;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME REGULATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTONE METHYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRION; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN INTERACTION; ANIMAL; BINDING SITE; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; IMMUNOBLOTTING; METABOLISM; METHYLATION; NEUROBLASTOMA; PATHOLOGY; PHOSPHORYLATION; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE; TWO HYBRID SYSTEM;

ANIMALS; ANTINEOPLASTIC AGENTS; BINDING SITES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; GENE EXPRESSION REGULATION; HEK293 CELLS; HISTONES; HUMANS; IMMUNOBLOTTING; LYSINE; METHYLATION; MITOCHONDRIA; NEUROBLASTOMA; PHOSPHORYLATION; POLYCOMB REPRESSIVE COMPLEX 2; PROTEIN BINDING; PROTEIN KINASES; PROTEIN TRANSPORT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRETINOIN; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84883434396     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1419356111     Document Type: Erratum

References (49)

1. Hardy J, Cai H, Cookson MR, Gwinn-Hardy K, Singleton A (2006) Genetics of Parkinson's disease and parkinsonism. Ann Neurol 60(4):389-398. (Pubitemid 44684974)
2. Lesage S, Brice A (2012) Role of mendelian genes in "sporadic" Parkinson's disease. Parkinsonism Relat Disord 18(suppl 1):S66-S70.
3. Valente EM, et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304(5674):1158-1160. (Pubitemid 38661852)
4. Mills RD, et al. (2008) Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1). J Neurochem 105(1):18-33. (Pubitemid 351441646)
5. Haque ME, et al. (2008) Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP. Proc Natl Acad Sci USA 105(5):1716-1721. (Pubitemid 351346580)
6. Murata H, et al. (2011) A new cytosolic pathway from a Parkinson disease-associated kinase, BRPK/PINK1: Activation of AKT via mTORC2. J Biol Chem 286(9):7182-7189.
7. Pridgeon JW, Olzmann JA, Chin LS, Li L (2007) PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol 5(7):e172.
8. Plun-Favreau H, et al. (2007) The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol 9(11):1243-1252. (Pubitemid 350042356)
9. Chen Y, Dorn GW, 2nd (2013) PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria. Science 340(6131):471-475.
10. Kim Y, et al. (2008) PINK1 controls mitochondrial localization of Parkin through direct phosphorylation. Biochem Biophys Res Commun 377(3):975-980.
11. Sha D, Chin LS, Li L (2010) Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling. Hum Mol Genet 19(2):352-363.
12. Narendra DP, Youle RJ (2011) Targeting mitochondrial dysfunction: Role for PINK1 and Parkin in mitochondrial quality control. Antioxid Redox Signal 14(10):1929-1938.
13. Pilsl A, Winklhofer KF (2012) Parkin, PINK1 and mitochondrial integrity: Emerging concepts of mitochondrial dysfunction in Parkinson's disease. Acta Neuropathol 123(2):173-188.
14. Henn IH, et al. (2007) Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling. J Neurosci 27(8):1868-1878.
15. Gandhi S, et al. (2009) PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol Cell 33(5):627-638.
16. Marongiu R, et al. (2009) Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux. J Neurochem 108(6):1561-1574.
17. Cheung P, Lau P (2005) Epigenetic regulation by histone methylation and histone variants. Mol Endocrinol 19(3):563-573. (Pubitemid 40349431)
18. Margueron R, Reinberg D (2011) The Polycomb complex PRC2 and its mark in life. Nature 469(7330):343-349.
19. Simon JA, Kingston RE (2009) Mechanisms of polycomb gene silencing: Knowns and unknowns. Nat Rev Mol Cell Biol 10(10):697-708.
20. Kuzmichev A, Jenuwein T, Tempst P, Reinberg D (2004) Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol Cell 14(2):183-193. (Pubitemid 38515646)
21. Rietzler M, Bittner M, Kolanus W, Schuster A, Holzmann B (1998) The human WD repeat protein WAIT-1 specifically interacts with the cytoplasmic tails of beta7-integrins. J Biol Chem 273(42):27459-27466. (Pubitemid 28500464)
22. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K (2006) Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 20(9):1123-1136.
23. Prezioso C, Orlando V (2011) Polycomb proteins in mammalian cell differentiation and plasticity. FEBS Lett 585(13):2067-2077.
24. Aldiri I, Vetter ML (2012) PRC2 during vertebrate organogenesis: A complex in transition. Dev Biol 367(2):91-99.
25. Montgomery ND, Yee D, Montgomery SA, Magnuson T (2007) Molecular and functional mapping of EED motifs required for PRC2-dependent histone methylation. J Mol Biol 374(5):1145-1157. (Pubitemid 350122552)
26. Han Z, et al. (2007) Structural basis of EZH2 recognition by EED. Structure 15(10):1306-1315. (Pubitemid 47539160)
27. Tie F, Siebold AP, Harte PJ (2005) The N-terminus of Drosophila ESC mediates its phosphorylation and dimerization. Biochem Biophys Res Commun 332(2):622-632. (Pubitemid 40725019)
28. Tie F, Furuyama T, Harte PJ (1998) The Drosophila Polycomb Group proteins ESC and E (Z) bind directly to each other and co-localize at multiple chromosomal sites. Development 125(17):3483-3496. (Pubitemid 28458347)
29. Ng J, Li R, Morgan K, Simon J (1997) Evolutionary conservation and predicted structure of the Drosophila extra sex combs repressor protein. Mol Cell Biol 17(11):6663-6672. (Pubitemid 27451213)
30. Beilina A, et al. (2005) Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc Natl Acad Sci USA 102(16):5703-5708. (Pubitemid 40559623)
31. Witte V, et al. (2004) HIV-1 Nef mimics an integrin receptor signal that recruits the polycomb group protein Eed to the plasma membrane. Mol Cell 13(2):179-190. (Pubitemid 38183265)
32. Berthier A, et al. (2011) PINK1 displays tissue-specific subcellular location and regulates apoptosis and cell growth in breast cancer cells. Hum Pathol 42(1):75-87.
33. Zhou C, et al. (2008) The kinase domain of mitochondrial PINK1 faces the cytoplasm. Proc Natl Acad Sci USA 105(33):12022-12027.
34. Shiba K, et al. (2009) Parkin stabilizes PINK1 through direct interaction. Biochem Biophys Res Commun 383(3):331-335.
35. Weihofen A, Thomas KJ, Ostaszewski BL, Cookson MR, Selkoe DJ (2009) Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking. Biochemistry 48(9):2045-2052.
36. Svineng G, Ravuri C, Rikardsen O, Huseby NE, Winberg JO (2008) The role of reactive oxygen species in integrin and matrix metalloproteinase expression and function. Connect Tissue Res 49(3):197-202.
37. Liu Z, Sekito T, Epstein CB, Butow RA (2001) RTG-dependent mitochondria to nucleus signaling is negatively regulated by the seven WD-repeat protein Lst8p. EMBO J 20(24):7209-7219. (Pubitemid 34062312)
38. Vives-Bauza C, et al. (2010) PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci USA 107(1):378-383.
39. Singer MS, et al. (1998) Identification of high-copy disruptors of telomeric silencing in Saccharomyces cerevisiae. Genetics 150(2):613-632. (Pubitemid 28463040)
40. Anichtchik O, et al. (2008) Loss of PINK1 function affects development and results in neurodegeneration in zebrafish. J Neurosci 28(33):8199-8207.
41. Billia F, et al. (2011) PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function. Proc Natl Acad Sci USA 108(23):9572-9577.
42. d'Amora M, et al. (2011) Expression of PINK1 in the brain, eye and ear of mouse during embryonic development. J Chem Neuroanat 41(2):73-85.
43. Påhlman S, et al. (1995) Differentiation and survival influences of growth factors in human neuroblastoma. Eur J Cancer 31A(4):453-458.
44. Lee ER, Murdoch FE, Fritsch MK (2007) High histone acetylation and decreased polycomb repressive complex 2 member levels regulate gene specific transcriptional changes during early embryonic stem cell differentiation induced by retinoic acid. Stem Cells 25(9):2191-2199. (Pubitemid 47480477)
45. Mattson MP, Meffert MK (2006) Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ 13(5):852-860.
46. Chase A, Cross NC (2011) Aberrations of EZH2 in cancer. Clin Cancer Res 17(9):2613-2618.
47. Richly H, Aloia L, Di Croce L (2011) Roles of the Polycomb group proteins in stem cells and cancer. Cell Death Dis 2:e204.
48. Xiao Y (2011) Enhancer of zeste homolog 2: A potential target for tumor therapy. Int J Biochem Cell Biol 43(4):474-477.
49. Andrés-Pons A, Gil A, Oliver MD, Sotelo NS, Pulido R (2012) Cytoplasmic p27Kip1 counteracts the pro-apoptotic function of the open conformation of PTEN by retention and destabilization of PTEN outside of the nucleus. Cell Signal 24(2):577-587.